(20 days)
Not Found
Not Found
No
The summary describes a simple monopolar electrode for delivering radio frequency energy, with no mention of AI, ML, image processing, or any data-driven decision-making components.
Yes
The device is intended for ablation and coagulation of soft tissue, which are therapeutic medical procedures.
No
The device is described as a monopolar electrode for delivering radio frequency energy for ablation and coagulation of soft tissue, which are therapeutic actions, not diagnostic ones.
No
The device description explicitly states it is a "monopolar electrode designed to deliver radio frequency energy," which is a hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for "ablation and coagulation of the soft tissue" using radio frequency energy. This is a therapeutic procedure performed directly on the patient's tissue.
- Device Description: The device is described as a "monopolar electrode designed to deliver radio frequency energy". This is a surgical tool.
- Lack of IVD Characteristics: There is no mention of analyzing samples (like blood, urine, tissue samples) in vitro (outside the body) to diagnose a condition. IVDs are used to provide information about a patient's health status based on the analysis of these samples.
Therefore, the Endolap Resectoscope Roller Electrode device is a surgical device used for therapeutic purposes, not an IVD.
N/A
Intended Use / Indications for Use
The Endolap Resectoscope Roller Electrode device is a monopolar electrode designed to deliver radio frequency energy that is supplied by an electrical generator cleared for medical use. The Endolap Resectoscope roller electrode device is indicated for ablation and coagulation of the soft tissue and is intended for use with compatible resectoscopes.
Product codes (comma separated list FDA assigned to the subject device)
78 FAS, 78 FDC
Device Description
Not Found
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Not Found
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc)
Not Found
§ 876.4300 Endoscopic electrosurgical unit and accessories.
(a)
Identification. An endoscopic electrosurgical unit and accessories is a device used to perform electrosurgical procedures through an endoscope. This generic type of device includes the electrosurgical generator, patient plate, electric biopsy forceps, electrode, flexible snare, electrosurgical alarm system, electrosurgical power supply unit, electrical clamp, self-opening rigid snare, flexible suction coagulator electrode, patient return wristlet, contact jelly, adaptor to the cord for transurethral surgical instruments, the electric cord for transurethral surgical instruments, and the transurethral desiccator.(b)
Classification. Class II (performance standards).
0
Image /page/0/Picture/17 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo is circular in shape, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. In the center of the circle is a stylized symbol that resembles a person with their arms outstretched. The symbol is composed of three curved lines that overlap each other.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
DEC 2 2 1997
Mr. L. A. Tony Gilstrap Chief Operating Officer ENDOlap™, Inc. 3012 Mercy Drive Orlando, Florida 32808 Re: K974515
ENDOlap™ Resectoscope Roller Electrode Dated: November 15, 1997 Received: December 2, 1997 Regulatory class: II 21 CFR §876.4300/Product code: 78 FAS 21 CFR §876.1500/Product code: 78 FDC
Dear Mr. Gilstran:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under Radiation Control provisions, or other Federal laws or regulations.
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (2) CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for question and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
W.Liau Yu
Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
1
Page of
K974515 510(k) NUMBER (IF KNOWN):
Resctoscope Roller electrode DEVICE NAME:
INDICATIONS FOR USE:
The Endolap Resectoscope Roller Electrode device is a monopolar electrode designed to deliver radio frequency energy that is supplied by an electrical generator cleared for medical use. The Endolap Resectoscope roller electrode device is indicated for ablation and coagulation of the soft tissue and is intended for use with compatible resectoscopes.
(PLEASE DO NOT WRITE BELCW THIS LINE-CONTINUE ON ANCITER FAGE IF NEEDED.)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR
Over-The-Counter-Use
(Optional Format 1-2-96)
(Division Sign-Off)
Division of Reproductive, Abdominal, ENT,
and Radiological Devices
510(k) Number K974515